Citation: Dr. Rosenberg et al., Brain anatomy and chemistry may predict treatment response in paediatric obsessive-compulsive disorder, IN J NEUROP, 4(2), 2001, pp. 179-190
Authors:
Bolton, J
Moore, GJ
MacMillan, S
Stewart, CM
Rosenberg, DR
Citation: J. Bolton et al., Case study: Caudate glutamatergic changes with paroxetine persist after medication discontinuation in pediatric OCD, J AM A CHIL, 40(8), 2001, pp. 903-906
Authors:
Rosenberg, DR
Amponsah, A
Sullivan, A
MacMillan, S
Moore, GJ
Citation: Dr. Rosenberg et al., Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging, J CHILD NEU, 16(9), 2001, pp. 636-641
Authors:
Rosenberg, DR
MacMaster, FP
Keshavan, MS
Fitzgerald, KD
Stewart, CM
Moore, GJ
Citation: Dr. Rosenberg et al., Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine, J AM A CHIL, 39(9), 2000, pp. 1096-1103
Authors:
Rosenberg, DR
Benazon, NR
Gilbert, A
Sullivan, A
Moore, GJ
Citation: Dr. Rosenberg et al., Thalamic volume in pediatric obsessive-compulsive disorder patients beforeand after cognitive behavioral therapy, BIOL PSYCHI, 48(4), 2000, pp. 294-300
Citation: Dr. Rosenberg et Gl. Hanna, Genetic and imaging strategies in obsessive-compulsive disorder: Potentialimplications for treatment development, BIOL PSYCHI, 48(12), 2000, pp. 1210-1222
Authors:
Fitzgerald, KD
Moore, GJ
Paulson, LA
Stewart, CM
Rosenberg, DR
Citation: Kd. Fitzgerald et al., Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder, BIOL PSYCHI, 47(3), 2000, pp. 174-182
Authors:
Gilbert, AR
Moore, GJ
Keshavan, MS
Paulson, LAD
Narula, V
MacMaster, FP
Stewart, CM
Rosenberg, DR
Citation: Ar. Gilbert et al., Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine, ARCH G PSYC, 57(5), 2000, pp. 449-456
Citation: Sr. Beers et al., Cognitive deficits in obsessive-compulsive disorder - Dr. Deers and colleagues reply, AM J PSYCHI, 157(7), 2000, pp. 1183-1183
Authors:
Fitzgerald, KD
Stewart, CM
Tawile, V
Rosenberg, DR
Citation: Kd. Fitzgerald et al., Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder, J CH AD PSY, 9(2), 1999, pp. 115-123
Authors:
Rosenberg, DR
Stewart, CM
Fitzgerald, KD
Tawile, V
Carroll, E
Citation: Dr. Rosenberg et al., Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive disorder, J AM A CHIL, 38(9), 1999, pp. 1180-1185
Authors:
Mac Master, FP
Keshavan, MS
Dick, EL
Rosenberg, DR
Citation: Fp. Mac Master et al., Corpus callosal signal intensity in treatment-naive pediatric obsessive compulsive disorders, PROG NEUR-P, 23(4), 1999, pp. 601-612
Authors:
Beers, SR
Rosenberg, DR
Dick, EL
Williams, T
O'Hearn, KM
Birmaher, B
Ryan, CM
Citation: Sr. Beers et al., Neuropsychological study of frontal lobe function in psychotropic-naive children with obsessive-compulsive disorder, AM J PSYCHI, 156(5), 1999, pp. 777-779